NBIX Historical Earnings image   This NBIX historical earnings page last updated 11/3/2022
NBIX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/1/20220.39B
Q2 20228/4/20220.38B
Q1 20225/4/20220.31B
Q4 20212/11/20220.31B
Q3 202111/1/20210.30B
Q2 20218/3/20210.29B
Q1 20215/5/20210.24B
Q4 20202/4/20210.25B
Q3 202011/9/20200.26B
Q2 20208/3/20200.30B
Q1 20205/6/20200.24B
Q4 20192/4/20200.24B
Q3 201911/4/20190.22B
Q2 20197/29/20190.18B
Q1 20194/29/20190.14B
Q4 20182/5/2019131.49M
Q3 201811/5/2018151.76M
Q2 20187/31/201896.91M
Q1 20184/30/201871.09M
Q4 20172/13/201894.52M
Q3 201711/1/201760.77M
Q2 20178/3/20176.33M
Q1 20175/9/2017NA
Q4 20162/14/2017NA
Q3 201611/2/2016NA
Q2 20168/3/2016NA
Q1 20165/5/201615.00M
Q4 20152/11/2016NA
Q3 201510/29/2015NA
Q2 20157/29/2015NA
Q1 20154/30/201519.77M
Q4 20142/9/2015NA
Q3 201411/3/2014NA
Q2 20148/6/2014NA
Q1 20144/30/2014NA
Q4 201312/31/2013730000
Q3 201310/29/2013729000
Q2 20137/25/2013730000
Q1 20135/2/2013730000
Q4 20122/8/201321.90M
Q3 201210/31/201216.80M
Q2 20127/31/201210.60M
Q1 20125/2/201211.27M
NBIX Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202211/1/20221.080
Q2 20228/4/20220.840
Q1 20225/4/20220.300
Q4 20212/11/20220.040
Q3 202111/1/20210.640
Q2 20218/3/20210.630
Q1 20215/5/20210.490
Q4 20202/4/20210.910
Q3 202011/9/20200.970
Q2 20208/3/20201.420
Q1 20205/6/20200.820
Q4 20192/4/20201.050
Q3 201911/4/20190.560
Q2 20197/29/20190.320
Q1 20194/29/2019-1.120
Q4 20182/5/20190.19
Q3 201811/5/20180.52
Q2 20187/31/2018-0.07
Q1 20184/30/2018-0.47
Q4 20172/13/20180.07
Q3 201711/1/2017-0.13
Q2 20178/3/2017-0.68
Q1 20175/9/2017-0.9
Q4 20162/14/2017-0.51
Q3 201611/2/2016-0.43
Q2 20168/3/2016-0.46
Q1 20165/5/2016-0.22
Q4 20152/11/2016-0.34
Q3 201510/29/2015-0.4
Q2 20157/29/2015-0.28
Q1 20154/30/2015-0.01
Q4 20142/9/2015-0.26
Q3 201411/3/2014-0.21
Q2 20148/6/2014-0.18
Q1 20144/30/2014-0.17
Q4 201312/31/2013-0.16
Q3 201310/29/2013-0.17
Q2 20137/25/2013-0.18
Q1 20135/2/2013-0.18
Q4 20122/8/20130.14
Q3 201210/31/2012-0.05
Q2 20127/31/2012-0.01
Q1 20125/2/2012-0.01
Quotes delayed 20 minutes

Email EnvelopeFree NBIX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Neurocrine Biosciences (NBIX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NBSE Historical Earnings
NDRA Historical Earnings
NEO Historical Earnings
NEOG Historical Earnings
NERV Historical Earnings
NEXI Historical Earnings
NGM Historical Earnings
NKTR Historical Earnings
NKTX Historical Earnings
NLTX Historical Earnings
What was the record high NBIX historical earnings result?
In terms of earnings or revenue, what is the best NBIX historical earnings result that Neurocrine Biosciences has ever posted, and when?

✔️Accepted answer: Within our data set, the highest NBIX historical earnings result was set in Q2 2020, when Neurocrine Biosciences posted results of 1.420/share. The most successful revenue quarter within our data set was Q3 2022 when Neurocrine Biosciences reported revenue of 0.39B.

What was the lowest Neurocrine Biosciences historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest NBIX has reported, and when?

✔️Accepted answer: Within our data set, the lowest NBIX historical earnings result was set in Q1 2019, when Neurocrine Biosciences posted results of -1.120/share. The smallest revenue quarter within our data set was Q1 2017 when Neurocrine Biosciences reported revenue of NA.

On this page we presented the NBIX historical earnings date information for Neurocrine Biosciences. Reviewing that NBIX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2020, when NBIX posted adjusted EPS of 1.420/share. Meanwhile the lowest NBIX historical earnings result was in Q1 2019, when NBIX posted adjusted EPS of -1.120/share. Moving to Neurocrine Biosciencess historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2022 when NBIX reported 0.39B in revenue, while the smallest revenue quarter was Q1 2017 when NBIX reported NA in revenue.

For self directed investors doing their due diligence on NBIX or any other given stock, their research can benefit from looking into all of the Neurocrine Biosciences historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Neurocrine Biosciences historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for NBIX. Thanks for visiting, and the next time you need to research NBIX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: RMBL YTD Return, HIHO Average Annual Return, Funds Holding MCK.

 

NBIX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.